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The elimination of antigens by B lymphocytes 
is performed by antibody molecules that con-
tain an N-terminal variable domain followed 
by a C-terminal constant domain. During the 
immune response, B lymphocytes express the 
activation-induced cytidine deaminase (AID) 
enzyme, which induces two major alterations 
in Ig gene loci to enhance antibody and B cell 
function. First, the process of somatic hyper-
mutation introduces single point mutations at 
variable genes, which can increase antibody af-
fi  nity for antigens (1). Second, the mechanism 
of class switch recombination replaces the Ig 
heavy chain constant region Cμ for Cγ, Cε, 
or Cα, thereby controlling the antibody eff  ec-
tor function (2).
The importance of AID in the humoral im-
mune response is highlighted in AID-defi  cient 
patients and animals, which are highly suscep-
tible to infection and exhibit gut fl  ora–dependent 
hyperplasia of intestinal villi (3, 4). Conversely, 
complex diseases such as autoimmunity have 
long been associated with AID-dependent hyper-
mutation (5). Moreover, untimely, ectopic, or 
elevated AID expression results in transloca-
tions and malignant transformation of B cells 
(6, 7) and T cells (8). These considerations em-
phasize the need to understand the molecular 
pathways that regulate AID expression during 
B cell ontogeny.
Initially, AID expression was thought to 
be limited to follicular germinal center (GC) 
B cells (9). Conversely, recent evidence sug-
gests that AID is also active outside of the GC 
microenvironment. In mice carrying a highly 
reduced V gene repertoire, hypermutation and 
AID transcripts were reported in a small subset 
of immature bone marrow B cells (10). In a 
  lupus-prone mouse, hypermutation and affi   nity 
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The B cell–specifi  c enzyme activation-induced cytidine deaminase (AID) has been shown 
to be essential for isotype switching and affi  nity maturation of antibody genes during the 
immune response. Conversely, AID activity has also been linked to autoimmunity and tu-
morigenesis. Determining how AID expression is regulated in vivo is therefore central to 
understanding its role in health and disease. Here we use phylogenetic footprinting and 
high-resolution histone acetylation mapping to accurately demarcate AID gene regulatory 
boundaries. Based on this strategy, we identify a novel, positive regulatory element required 
for AID transcription. Furthermore, we generate two AID indicator mouse strains using 
bacterial artifi  cial chromosomes that faithfully recapitulate endogenous AID expression. 
The fi  rst strain uses a green fl  uorescent protein reporter to identify B cells that actively 
express AID during the immune response. In the second strain, AID transcription affects 
the permanent expression of a yellow fl  uorescent protein reporter in post–germinal 
center and terminally differentiated lymphocytes. We demonstrate the usefulness of 
these novel strains by resolving recent contradictory observations on AID expression 
during B cell ontogeny.
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maturation occur at the T cell zone–red pulp border (11). 
Likewise, in rheumatoid arthritis patients, somatic hyper-
mutation has been shown to occur in B cells residing in 
nonlymphoid synovial tissue (12). In normal mice, AID tran-
scription and class switch recombination might occur in the 
gut lamina propria outside of Peyer’s patches (PPs) and isolated 
lymphoid follicles (ILFs) (13), although others have recently 
contradicted these fi  ndings (14). Large extrafollicular prolif-
erating cells have also been shown to express AID in human 
lymphoid tissues (15, 16). Finally, recent data indicate that 
AID is induced in pre–B cells in response to retroviral infec-
tion, perhaps as part of an innate defense mechanism (17). 
These studies therefore underscore the need for experimental 
model systems to monitor AID expression in the context 
of the entire organism.
The development of indicator mouse strains using bacte-
rial artifi  cial chromosomes (BACs) has greatly facilitated the 
study of gene expression and the unraveling of gene regula-
tory elements in the past decade (18, 19). The success of gene 
reporter expression systems is based on the premise that trans-
gene constructs must carry suffi   cient regulatory information 
to recapitulate tissue-specifi  c and copy-dependent regulation 
of genes of interest. However, the in vivo demarcation of 
gene regulatory boundaries typically relies on the production 
of large cohorts of transgenic animals (20, 21), making this 
process expensive and time-consuming. We here provide an 
alternative approach that combines comparative genomic 
analysis with high-resolution histone H3 acetylation map-
ping. This strategy allowed us to predefi  ne the minimal DNA 
segment capable of recapitulating the temporal and spatial ex-
pression patterns of endogenous AID and led to the develop-
ment of two complementary AID reporter lines that effi   ciently 
track AID-expressing cells as well as their progeny. Our 
  studies defi  ne AID expression during T cell–dependent and 
–  independent immune responses as well as upon retroviral 
infection of immature B cells.
RESULTS
Mapping AID gene regulatory boundaries
To identify the cis-regulatory elements governing AID tran-
scription in vivo, we used phylogenetic footprinting to com-
pare one megabase of human, dog, and mouse genomic DNA 
containing the AID (Aicda) gene. Using a combination of 
global and local alignment algorithms (http://family.caltech
.edu/ and http://www-gsd.lbl.gov/vista/index.shtml), we gen-
erated alignment plots that revealed the conserved protein-
encoding sequences (exons) of three syntenic genes within 
the one megabase of genomic DNA analyzed: Kiaa1238, 
Mfap5, and Aicda (Fig. 1, red peaks). Additionally, we found 
11 highly conserved noncoding sequences (CNSs) that ex-
hibited on average ≥75% identity in all three species (Fig. 1, 
black peaks).
To examine potential contributions of CNSs to AID 
transcription, we explored their ability to attract histone acetyl-
transferase activity in B cells stimulated with LPS and IL-4 in 
vitro. Hyperacetylation of core histones in transcribed genes 
results in part from the interaction of transcription factors 
with regulatory elements, such as promoters and enhancers 
(22). To monitor changes in chromatin acetylation at high 
resolution, we assessed the percentage of acetylated histone 
H3 by chromatin immunoprecipitation and real-time PCR 
analysis (Fig. 2 A). In mature resting B cells, which do not 
express AID, we found H3 acetylation across Aicda at low 
levels (<10%; Fig. 2 B, blue circles). This acetylation was 
comparable to the calculated H3 acetylation in the mamma-
lian genome (8%; see Materials and methods) as well as in 
neighboring genes such as Mfap5 (Fig. 2 B), which is not 
appreciably transcribed in B cells (not depicted).
Figure 1.  Phylogenetic analysis of Aicda. AID locus in human chro-
mosome 12. Homology “peaks and valleys” graph showing percent con-
servation between human, dog, and mouse AID genomic loci. The 
nucleotide sequence is plotted on the horizontal axis. The vertical axis 
depicts the percent identity between the three species. Only conserved 
regions containing at least one peak with percent identity >75% within 
a shifting window of 100 bp in all three species are represented. Red 
peaks correspond to gene exons, whereas black peaks denote CNSs (I–XI). 
Genes and their orientation are represented by their RefSeq name and by 
arrows, respectively. As in the human, the mouse and dog Mfap5 and 
Kiaa1238 orthologs are located 5′ of Aicda and form a synteny group 
within the 1 MB interval analyzed. Conversely, the mouse and dog Clecsf9 
and Clecsf8 genes are located beyond the 1 MB sequence analyzed here, 
and no homology is therefore assigned to these genes. Alignment was 
obtained using Family Relations (http://family.caltech.edu/) and VISTA 
software (http://www-gsd.lbl.gov/vista/index.shtml).JEM VOL. 204, May 14, 2007  1147
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In contrast to resting lymphocytes, B cells activated with 
LPS and IL-4, which induces AID transcription, showed a 
dramatic increase in H3 acetylation at the Aicda locus. Nearly 
all nucleosomes of AID exon 1 and its vicinity (correspond-
ing to CNS VIII) were acetylated (Fig. 2 B, red squares). This 
fi  rst peak of acetylation included an intronic regulatory ele-
ment shown to bind E proteins during AID expression (23). 
Acetylation was decreased at exons 2–5 (50–70%), and a fur-
ther decrease to basal acetylation levels was observed near 
Aicda’s polyA signal sequences. These results are consistent 
with the notion that acetylation signals are propagated over 
the chromatin of coding regions through interactions of his-
tone acetyltransferases and transcription complexes (24).
Unlike CNS I–VII and XI, which exhibited no change in 
H3 acetylation upon B cell activation (Fig. 2 B and not de-
picted), a second acetylation peak occurred at CNS X. This 
element, located  7 kb downstream of mouse Aicda (Fig. 2 A) 
or  24 kb 3′ of human Aicda (Fig. 1), is composed of two 
elements highly conserved in humans and mice (Fig. 2 D). 
To investigate whether CNS X functions as a bona fi  de 
  protein-binding site upon AID transcription, we performed 
DNaseI hypersensitivity assays on nuclei obtained from resting 
Figure 2.  H3 acetylation status at the AID locus. (A) Percent homol-
ogy identity between the dog, human, and mouse genomes as a function 
of the mouse AID locus in chromosome 6. Homology peaks and genes are 
depicted as in Fig. 1. Black dots represent the position of quantitative PCR 
primers used to assess H3 acetylation by CHIP. AID exons are marked with 
yellow boxes. E, EcoRV; S, SalI; X, XbaI. (B) Absolute percentage of histone 
H3 acetylation from resting (blue circles) or LPS-activated (red squares) 
B cells. (C) DNaseI hypersensitivity at CNS VII and X. Nuclei prepared 
from LPS-activated mouse B cells were untreated (lane 1) or treated with 
  increased concentrations of DNaseI (lanes 2–6). DNA was extracted, 
  digested, and analyzed by Southern blot hybridization using VII- or 
X-specifi  c probes (PVII and PX, respectively). Horizontal arrows indicate 
  DNaseI hypersensitive sites that correlate with CNS-X. (D) Detailed map 
of mouse CNS X. Elements A and B (red boxes) depict two highly 
  conserved sequences between mouse and humans that correlate with 
the Southern blot bands obtained by DNaseI hypersensitivity. Putative 
transcription factor binding sites in elements A and B, predicted using 
VISTA software, are shown.1148  AID REPORTER MICE | Crouch et al.
and activated B lymphocytes. In contrast to CNS VII, which 
is not hyperacetylated during B cell activation (Fig. 2 C, left), 
we found clear evidence of protein binding at CNS X (Fig. 2 C, 
right), strongly suggesting that this element functions as a 
regulator of AID transcription.
Monitoring in vivo AID expression using AID-GFP 
reporter mice
The above studies predicted that AID proximal promoter ele-
ments and CNS X might be suffi   cient to direct physiological 
expression of an AID reporter gene. To evaluate this hypo-
thesis, we generated transgenic mice with a 45-kb BAC carry-
ing the mouse AID gene, including CNS X (Fig. 2 D and Fig. 
3 A, top). By means of homologous recombination (25), we 
modifi  ed the BAC by fusing the GFP gene to AID exon 5. To 
defi  ne the role of CNS X in AID expression, we also created 
a second transgene construct in which CNS X was deleted by 
recombination (AID-GFP-∆X; Fig. 3 A, bottom). Two AID-
GFP and three AID-GFP-∆X transgenic mouse strains were 
generated with two to fi  ve transgenic copies per line.
Transgenic mice and wild-type littermates were immunized 
in the front footpads with the conjugated hapten nitrophenol 
(NP)-CGG. 5 d after immunization, we developmentally 
staged axillary lymph node B lymphocytes by fl  ow cytometry 
using a panel of cell surface markers, including the B cell GC 
marker CD95. Unlike nontransgenic littermates (Fig. 3 B, 
left), nearly all CD95high GC B cells in AID-GFP mice exhib-
ited green fl  uorescence (Fig. 3 B, middle). AID-GFP was ab-
sent in resting B220+ B cells (Fig. 3 B, middle, CD95low), 
bone marrow B cell populations (discussed below), and thy-
mic or peripheral CD4+ or CD8+ T cells (not depicted). 
This GFP expression pattern matches the reported transcrip-
tion profi  le of AID (9). The coordinate expression of AID-
GFP and endogenous AID mRNA was validated by real-time 
PCR in resting and LPS plus IL-4–activated B lymphocytes 
(Fig. 3 C). In addition, RT-PCR analysis of seven mouse tis-
sues revealed that AID expression is circumscribed to lym-
phoid organs both in wild-type and transgenic animals (Fig. 
S1). Analysis of the three transgenic AID-GFP-∆X lines 
showed no green fl  uorescence in GC B cells in the absence 
of CNS X (Fig. 3 B). Furthermore, PCR analysis showed a 
fi  ve- to sevenfold decrease in AID-GFP transcripts in acti-
vated AID-GFP-∆X lymphocytes compared with AID-GFP 
controls (Fig. 3 C). We conclude that our AID-GFP trans-
gene recapitulates the spatiotemporal expression of endoge-
nous AID and that CNS X is required for AID transcription 
during the immune response.
Activated B cells leaving the GC diff  erentiate into plasma 
or memory B cells. To examine whether AID expression is 
maintained or down-regulated as B cells exit the GC micro-
envi  ronment, we assessed green fl  uorescence in post-GC B 
cells during the NP response. We fi  rst analyzed pre-plasma 
memory B cells (NP+IgD−B220−CD138−) (26, 27) in AID-
GFP mice immunized with NP-KLH. As described previ-
ously, these GC-derived B cells appear in the spleen 7–10 d 
after immunization, are somatically hypermutated, do not 
  secrete antibody, and persist after primary challenge (27). We 
found that although NP+B220+CD95high GC cells express 
abundant AID-GFP (Fig. 4 A, right), pre-plasma memory 
lymphocytes lack AID-GFP expression (Fig. 4 A, middle) 
suggesting that AID is down-regulated as cells exit the GC 
microenvironment. To confi  rm this result, we assessed AID 
transcription in post-GC NP-binding cells recovered from 
the blood of nontransgenic animals. NP-specifi  c IgG1+ B cells 
carrying somatic mutations appear in the blood as early as 7 d 
after immunization (28). To determine AID mRNA levels in 
this small compartment, we developed a single cell RT-PCR 
strategy (SC-RT-PCR; see Materials and methods). Consis-
tent with previous observations (28), few NP-specifi  c B cells 
were found in unimmunized mice (Fig. 4 B, day 0), whereas 
7 d after NP-CGG immunization, B220+IgG1+NP+ B cells 
were clearly present in the blood (Fig. 4 B, day 7). We found 
that although nearly all (70 of 72) B220+IgG1+NP+CD95high 
lymph node GC cells were AID+ at day 7, AID transcripts 
were absent in B220+IgG1+NP+blood lymphocytes (Fig. 
4 B). In agreement with these observations, no AID-GFP+ 
cells were observed in the blood of AID-GFP–immunized 
mice (not depicted).
Figure 3.  AID expression in AID-GFP and AID-GFP-𝖫X transgenic 
mice. (A) Molecular schemes of AID-GFP and AID-GFP-∆X transgenes. 
The position of CNS X is indicated. (B) FACS analysis of AID expression in 
wild-type (left) and transgenic mice (middle and right) immunized with 
NP-CGG and CFA. Cells were stained with CD95-PE and gated on B220 
(PercP-Cy5.5). Apoptotic cells were excluded by To-Pro-3 or DAPI staining. 
The GC nature of GFP+ cells was confi  rmed by GL7-APC staining (not 
depicted). (C) Endogenous AID (gray bars), AID-GFP (green bars), and AID-
GFP-∆X (red bars) transcripts were measured by quantitative PCR from 
resting, LPS, or LPS plus IL-4 stimulated B lymphocytes. The diagram on 
the left depicts primer positions.JEM VOL. 204, May 14, 2007  1149
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To determine AID expression in T cell–independent 
  immune responses, we analyzed AID-GFP mice carrying the 
NP-specifi  c heavy chain B1-8 (B1-8hi) (29). 5 d after NP-
  Ficoll intraperitoneal injection, B1-8hi mice develop T cell–
independent GCs (B220+CD95highCD138low B cells) and large 
numbers of B220−CD138high plasma cells in the spleen (29). 
We found that GC cells express abundant AID-GFP after 
NP-Ficoll challenge (48% of B220+CD138low cells [Fig. 4 C], 
but nearly 100% of CD95high cells within that population [not 
depicted]). AID-GFP was, however, absent in terminally dif-
ferentiated B220−CD138high plasma cells (Fig. 4 C, population 
4), as determined both by fl  ow cytometry and SC-RT-
PCR analysis, a result consistent with the reported down-
regulation of AID mRNA in plasma cells (30). Yet, a subset 
of B220+CD138high plasmablasts expressed AID mRNA, 
AID-GFP, and high levels of CD95 (Fig. 4 C, population 3). 
These lymphocytes might represent an intermediate stage 
  between B220+CD138lowCD95high GC cells and fully dif-
ferentiated B220+CD138high plasmacytes (31). Collectively, 
our data demonstrate that AID is expressed both in T cell–
dependent and –independent GCs, but it is extinguished as 
B  lymphocytes exit the GC microenvironment either as 
memory or plasma cells.
Genetic labeling of B lymphocytes after AID expression
As stated above, the AID-GFP transgene and endogenous 
AID are activated in GC cells undergoing switching and/or 
hypermutation, but turned off   during plasma and memory 
B cell diff  erentiation. To permanently tag the progeny of 
AID-expressing B cells with a fl  uorescent reporter protein, 
we introduced the bacterial cre recombinase gene in lieu of 
AID exon 1 (Fig. 5 A). AID-Cre transgenic mice were bred 
to the ROSA26-EYFP reporter strain, in which the yellow 
fl  uorescent protein (YFP) is expressed indelibly upon Cre-
mediated deletion of a fl  oxed neomycin gene (Fig. 5 A) (32). 
To evaluate the interplay of the two transgenes in vivo, we 
measured yellow fl  uorescence in diff  erent B cell subsets from 
AID-Cre-YFP double transgenic mice. Six different founder 
lines with approximately one to fi  ve transgene copies were 
analyzed. We found no YFP expression in immature bone 
marrow B cells (see below) or other hematopoietic lineage 
cells (not depicted). In addition, the spleen or axillary lymph 
Figure 4.  Dynamics of AID expression in T cell–dependent and 
–independent immune responses. (A) AID-GFP mice were immunized 
with NP-CGG, and CD4−CD8−IgD−PI (or DAPI)− lymphocytes recognizing 
NP were subdivided by B220 expression (left) and assessed for CD138 and 
AID-GFP expression 7–10 d after immunization (middle and right). Anti-
bodies were IgD-biotin/Streptavidin-PE-Cy5, CD4-PE-Cy5, CD8-PE-Cy5, 
NP-APC, CD95-PE-Cy7, B220-APC-Cy7, and CD138-PE. (B) Left: NP stain-
ing of blood lymphocytes (IgM−IgD−Gr-1−F4/80−) recovered from unim-
munized (day 0) and NP-CGG–immunized (day 7) wild-type mice. Staining 
was To-Pro-3, F4/80-Alexa 647, GR1-Alexa 647, IgM-APC, IgD-Alexa 647 
(Dump channel) and NP-PE, IgG1-Biotin-Streptavidin-PercPCy5.5, and 
B220-FITC. Right: Analysis of AID transcription by SC-RT-PCR. NP+ cells 
were recovered by cell sorting from blood (72 cells analyzed) or lymph 
node GCs (72 cells) isolated from wild-type or AID−/− mice. (C) Left: AID-
GFP animals carrying the pre-recombined B1-8hi heavy chain gene were 
immunized with NP-haptenated Ficoll and splenic B cells analyzed 5 d 
after immunization. AID-GFP expression in resting (B220+CD138−), T cell–
independent GC (B220+CD138low), plasmablasts (B220+CD138high), and 
plasma cells (B220−CD138high) is indicated with histograms. Bottom his-
tograms show CD95 expression in AID-GFP+ cells from population 3 or 
population 4. Right: Analysis of AID transcription by SC-RT-PCR in the 
indicated populations isolated from B1-8hi mice.1150  AID REPORTER MICE | Crouch et al.
nodes of nonimmunized mice, which have few GCs, showed 
a small number of lymphocytes expressing YFP (Fig. 5 B, 
left). In contrast, we found that PPs, which harbor constitu-
tive GCs due to persistent B cell stimulation with gut anti-
gens, had large numbers ( 20% of B220+) of CD95highYFP+ 
GC cells (Fig. 5 B, right), demonstrating that AID transcrip-
tion promotes Cre expression in activated B cells. Consistent 
with this idea, virtually all lamina propria CD138+ plasma 
cells, which originate in PPs and possibly other sites of B cell 
activation, were YFP+ in AID-Cre-YFP mice (Fig. 5 C).
In both axillary lymph nodes and PPs, we consistently 
found resting B220+CD95low B cells expressing YFP (Fig. 5 B). 
These lymphocytes likely include post-GC memory and 
plasma cells that have undergone affi   nity maturation. To test 
this prediction, we evaluated the presence of somatic hyper-
mutation in these lymphocytes by cloning and sequencing 
their JH4 intron. We found that B220+CD95lowYFP+ lym-
phocytes carry a similar amount of mutations to that mea-
sured in GC B cells from AID-GFP mice (Fig. 5 D). This 
result indicates that this population largely derives from acti-
vated follicular B cells. Collectively, our results demonstrate 
that the AID-Cre and ROSA-Neo-YFP transgenes effi   ciently 
tag the progeny of AID-expressing B cells.
AID in the GALT
IgA, together with innate mucosal immunity, provides the 
fi  rst line of defense against bacterial antigens in the GALT. 
AID expression and class switching to IgA have been pro-
posed to take place either in situ in the gut lamina propria 
(13) or within GCs in PPs and ILFs of the small intestine (14). 
To ascertain the site of AID expression in mucosal surfaces, 
we determined green fl  uorescence in AID-GFP lymphocytes 
isolated from small intestine PPs and large intestine lamina 
propria. Under specifi  c pathogen-free conditions, the large 
intestine (which normally lacks PPs) fails to develop ILF GCs 
(unpublished data). We found little AID-GFP expression in 
B220+IgM+ PP B cells (Fig. 6 A, middle). In contrast, around 
65% of all B220+IgA+ PP cells expressed AID and high levels 
of CD95 (Fig. 6 A, right panel and top histogram, respec-
tively), indicating that PP GCs are primarily populated by 
IgA+ lymphocytes. As in PPs, B220+IgM+ B cells of the 
large intestine lamina propria displayed little green fl  uores-
cence (Fig. 6 B, left). However, a population of B220+IgA+ 
B lymphocytes expressed AID-GFP and high levels of CD95 
in the large intestine (Fig. 6 B, right, and Fig. 6 A, bottom 
histogram, respectively). IgA+CD95highAID-GFP+ lamina 
propria B cells may represent lymphocytes stimulated in situ 
perhaps by gut antigens as proposed previously (13). Alterna-
tively, these lymphocytes could be recently emigrated PP or 
ILF B cells carrying residual AID-GFP protein. To evaluate 
these possibilities, we determined green fl  uorescence in the 
lamina propria of AID-GFP-OcaB−/− mice. In the absence 
of OcaB, the capacity of B lymphocytes to form pauciclonal 
aggregates and diff  erentiate into plasmacytes in T cell–rich 
areas of lymphoid organs is intact, whereas B cell transloca-
tion to follicles and GC formation is impaired (33–35). 
In consequence, OcaB−/− mice lack both PPs, ILFs in the 
gut, and GCs in mesenteric lymph nodes (Fig. 6 C, micro-
graphs, and not depicted) (33–35). We found that OcaB−/−
AID-GFP mice, although unable to form GCs, displayed 
IgA+CD95highAID-GFP+ B cells in the large intestine lamina 
propria (Fig. 6 C, right), although at lower levels compared 
with wild-type animals (Fig. 6 B, right). To determine whether 
Figure 5.  Permanent labeling of B cells expressing AID. (A) Upper 
schematics: molecular maps of the AID-Cre (top) and Rosa-Neo-EYFP 
(bottom) transgenes (S, SalI; P, PacI; E, EcoRI). Lower Southern blot: three 
independent AID-Cre transgenic lines were generated, with copy number 
ranging between 1 to 5 copies. (B) FACS pseudocolor plots showing 
CD95-PE and YFP expression in B cells (gated on B220 (PercP-Cy5.5)) from 
AID-Cre-YFP compound mice. Left panel: axillary lymph node cells from 
nonimmunized mice; right panel: PPs. (C) Immunofl  uorescence analysis of 
gut lamina propria CD138+ plasma cells from AID-Cre-YFP mice. Scale 
bar = 20μm. (D) Mutation analysis of the JH4 intron from CD95lowYFP+, 
CD95highGFP+, CD95highGL7+ lymph node cell sorted from immunized 
AID-Cre-YFP, AID-GFP+, and AID−/− mice, respectively. Segments in pie charts 
are sized in proportion to the number of sequences carrying mutations as 
indicated. The number of sequences analyzed is given in the center of the 
pie charts. Mutation frequency and P values are indicated below. Statisti-
cal signifi  cance was assessed by a two-tailed t test assuming unequal 
variance and comparing values to mutation background determined in 
AID−/− sequences.JEM VOL. 204, May 14, 2007  1151
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AID-GFP+ B cells showed ongoing AID transcription, we 
performed SC-RT-PCR. We found evidence of AID 
mRNA in nearly all CD95high lymphocytes analyzed, whereas 
AID was rarely found in CD95low cells (Fig. 6 C, bottom). 
Collectively, our results demonstrate that gut lamina propria 
B cells can express AID outside of PPs and ILF GCs.
AID expression in immature B lymphocytes
Hypermutation in “GALT species,” including rabbit, sheep, 
and cattle, diversifi  es the preimmune repertoire before anti-
gen B cell stimulation (36). In contrast, V(D)J hypermuta-
tion in normal mice and humans is widely believed to be 
restricted to the GC microenvironment. This view has been 
recently challenged by fi  ndings showing AID expression and 
hypermutation in immature bone marrow B cells in mice 
expressing a highly restricted Ig repertoire (quasimonoclonal 
[QM] mice) (10). To determine whether AID is present in 
developing lymphocytes from wild-type mice, we character-
ized bone marrow B cells from AID-GFP and AID-Cre-YFP 
mice. We found that AID-GFP was absent from pro–/pre–B 
(B220lowIgM−), transitional (B220lowIgM+), and mature re-
circulating bone marrow B cells (B220highIgM+) recovered 
from AID-GFP transgenics (Fig. 7 A, left, pseudo-color plot, 
and middle). Likewise, YFP was undetectable in immature 
and transitional B cells (Fig. 7 A, right, 1 and 2). However, 
in all mice analyzed, we found a subset of mature recirculat-
ing B cells expressing YFP, which might represent post-GC 
lymphocytes (Fig. 7 A, right, 3). To investigate whether the 
apparent absence of AID expression in immature B cells was 
due to low expression of fl  uorescent proteins in our reporter 
animals, we quantifi  ed AID transcription in sorted bone mar-
row B cell populations using real-time PCR. Background 
levels of AID mRNA in pro–/pre–B cells corresponded to a 
10−3 dilution of PCR template prepared from B220+CD95high 
GC B lymphocytes isolated by cell sorting from the lymph 
nodes of   immunized mice (Fig. 7 B). In agreement with pub-
lished semiquantitative PCR analysis (10), AID transcripts 
were consistently detected in CD93+IgM+ bone marrow 
lymphocytes and splenic mature B cells, but AID expres-
sion levels in these cells were 100–500-fold lower than those 
  measured in GC lymphocytes (Fig. 7 B), and this transcrip-
tion was not suffi   cient to promote effi   cient Cre-mediated 
recombination or GFP   expression in our AID-Cre-YFP or 
AID-GFP indicator mice, respectively. Thus, unmanipulated 
mice show little AID   expression in immature B cells under 
normal conditions.
Recent data indicate that AID transcription can be in-
duced in pro– and pre–B cells upon infection with Abelson 
murine leukemia virus (Ab-MLV) (17), perhaps as part of 
an innate defense mechanism against viruses, as has been 
shown for other APOBEC protein family members (37, 38). 
To investigate whether retroviral infection leads to AID 
  expression in immature B cells, we monitored YFP fl  uores-
cence in AID-Cre-YFP transgenic bone marrow cells in-
fected with Ab-MLV in vitro. In these cultures, as in vivo, 
Ab-MLV infects with higher tropism a subset of developing 
B220lowCD43+IgM− B lymphocytes, leading to preferential 
cell proliferation and transformation (Fig. 7 C, 1 and 2) (39). 
We found little or no YFP expression in day 1–infected 
CD43+ bone marrow B cells (Fig. 7 C, 3). However, be-
tween 5 and 10% of the cultured cells expressed YFP 7 d after 
infection (Fig. 7 C, 4; three independent experiments). The 
presence of YFP+ lymphocytes is unlikely due to preferential 
expansion of rare YFP+ clones, as few immature B cells ex-
pressed YFP after IL-7-S17 stromal cell culture (Fig. 7 C, 5). 
To confi  rm induction of AID expression upon infection, we 
measured endogenous AID mRNA levels in Ab-MLV/AID-
Cre-YFP cultures by real-time PCR. We found that com-
pared with uninfected controls, AID transcripts were present 
in B220+CD43+YFP+ and B220+CD43+YFP− B cells at 
levels comparable to those found in GC lymphocytes (Fig. 7 C, 
bar graph). We conclude that in wild-type bone marrow B cells, 
AID is not appreciably transcribed, but AID expression can 
be induced upon retroviral infection.
DISCUSSION
Here we have described a rapid method to generate indicator 
transgenic mice that effi   ciently recapitulate endogenous ex-
pression of a gene of interest. This strategy, which relies on 
Figure 6.  AID expression in the GALT. AID expression in IgM (APC) or 
IgA (biotin/Streptavidin PercP-Cy5.5) B lymphocytes isolated from PPs (A) 
and lamina propria (LP; B) from AID-GFP mice (B220 was APC-Cy7 conju-
gated). Histograms show CD95 (PE) expression in the indicated popula-
tions. (C) Left micrographs: PNA staining of mesenteric lymph nodes 
(MLNs) isolated from OcaB+/+ and OcaB−/− mice (bar, 150 μm). Right 
density plot shows AID-GFP expression of IgA+ cells isolated from the 
lamina propria of AID-GFP-OcaB−/− mice. Bottom gel shows analysis of 
AID expression by SC-RT-PCR in the indicated B cell populations recov-
ered from OcaB−/− mice as indicated.1152  AID REPORTER MICE | Crouch et al.
phylogenetic footprinting and high-resolution   histone acety-
lation mapping, delineates gene regulatory boundaries with 
great accuracy. In general, using chromatin acetylation would 
seem an obvious approach when designing reporter trans-
genic constructs, although it is rarely used to its full   potential. 
One possible reason for its limited use might be the need to 
scan large segments of genomic DNA by chromatin immuno-
precipitation and PCR, as cis-regulatory   elements can be far 
removed from the genes they control (40). Such limitations 
could be easily overcome by high-throughput methods based 
on genomic DNA microarrays or similar ChiP-on-Chip 
technologies recently described (41, 42).
In this study, histone H3 acetylation mapping uncovered 
two elements at the mouse AID locus that undergo nearly 
complete acetylation upon B cell activation. The fi  rst ele-
ment corresponds to Aicda proximal promoter sequences, in-
cluding transcription-enhancing E2A binding sites (23). High 
levels of acetylation at these sites correlate with the reported 
ability of E-box proteins to recruit p300 acetyltransferase ac-
tivity to chromatin (43). Because evidence indicates that p300 
and E2A collaborate in B cell ontogeny (44), it will be im-
portant to determine whether the p300–E2A complex regulates 
AID gene transcription in activated B lymphocytes. The sec-
ond hyperacetylation element, termed CNS-X, is a putative 
Figure 7.  AID expression in immature, bone marrow B lympho-
cytes. (A) AID expression determined by fl  ow cytometry from bone mar-
row B220lowIgM− pro–/pre–B (population 1), transitional B220lowIgM+ 
(population 2), and recirculating B220highIgM+ (population 3) B lympho-
cytes obtained from AID-GFP (left histograms) or AID-Cre-YFP (right 
histograms) mice. All immature B cells were also CD93+ (not depicted). 
Antibodies were IgM-APC, B220-PercP-Cy5.5, CD93-biotin/Streptavidin-
PE, and To-pro-3. (B) Real-time PCR analysis of AID transcripts in pro–, 
pre–, transitional, mature, and PP B lymphocytes cell sorted from 
wild-type mice. For comparative purposes, cDNA synthesized from 
GL7+CD95high GC B cells was serially diluted, as indicated below each column. 
cDNA was amplifi  ed using PCR primers annealing to AID exons 2 and 3. 
All B cell populations were sorted to >95% purity before RNA extraction 
and cDNA synthesis. Vertical bars represent the standard deviation 
of three independent experiments. (C) Bone marrow cells from AID-Cre-
YFP mice were infected with Ab-MLV in vitro. The appearance of YFP+ 
cells was monitored in the infected cultures as a function of time (panels 
1–4; only days 1 and 7 after infection are shown). The images are repre-
sentative of three independent experiments. Panel 5 represents bone 
marrow B220+ cells isolated from AID-Cre-YFP mice and cultured for 7 d 
with IL-7 and in the presence of S17 cells. The following antibodies 
were used: CD43-PE, IgM-APC, B220-PercP-Cy5.5, and DAPI. Bar graph 
depicts the relative AID expression assessed by real-time PCR in 
Ab-MLV cultures.JEM VOL. 204, May 14, 2007  1153
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transcriptional enhancer, and its deletion nearly entirely abol-
ishes AID expression both in GC as well as in in vitro–activated 
B cells. DNaseI hypersensitivity assays demonstrate protein 
binding activity at CNS-X in activated B cells. Additional 
studies will be required to determine the nature of these fac-
tors and the mechanism by which they regulate AID gene 
transcription upon B cell activation.
Our reporter strains show that AID expression is induced in 
GC B cells both during T cell–dependent and –independent 
immune responses, and that memory and/or plasma cell dif-
ferentiation leads to AID transcriptional down-regulation. 
These results are consistent with previous studies showing 
that the transition of GC cells to the terminally diff  erentiated 
plasma cell stage is regulated by mutually exclusive transcrip-
tion programs (30). These gene regulatory networks, which 
depend on the activity of Pax5, Bcl6, IRF-4, and Blimp1, 
directly control AID gene expression as B cells diff  erentiate 
out of the GC microenvironment (45). However, as shown 
in mice that lack or have poorly developed PPs and ILFs, 
GCs are clearly not the only location for terminal B cell dif-
ferentiation (46, 47). Molecular characterization of lamina 
propria B cells indicates active, ongoing class switch recom-
bination outside of GCs (13). Our results using wild-type and 
OcaB−/−AID-GFP mice support the idea that AID expres-
sion is induced in situ in the GALT.
We fi  nd that under physiological conditions, bone mar-
row–developing B cells do not signifi   cantly express AID. 
Previous experiments with animals expressing a limited rep-
ertoire (QM mice) suggested that AID may function in im-
mature B cells (10). Similar conclusions were reached studying 
mMT−/− mice (48), where Igμ−δ− bone marrow B cells are 
arrested at the pro–B cell stage (49). In these animals, a small 
fraction of lymphocytes bypass the developmental block via 
class switch recombination, implying that AID is active at 
early stages of B cell development. However, both QM and 
mMT−/− diff  er from wild-type mice in that B lymphopoiesis 
occurs under strong selective pressure. Consequently, the 
physiological signifi  cance of bone marrow AID activity   under 
wild-type conditions was unclear. Our reporter strains show 
no evidence of AID expression in the bone marrow of ani-
mals with a normal antibody repertoire, and sensitive real-
time PCR analysis only detected AID transcripts in transitional 
CD93+IgM+ bone marrow B cells at levels 100–500-fold 
lower than those found in GC lymphocytes. Although we 
cannot rule out that under unique circumstances AID may 
play a role in early B cell lymphopoiesis, low levels of AID 
mRNA in the bone marrow of wild-type mice may be simply 
reminiscent of a common evolutionary past between mice and 
“GALT species” (36).
Although unperturbed bone marrow B cells show little 
AID expression, infection with a transforming retrovirus readily 
activates AID transcription in developing lymphocytes (17 
and this study). Likewise, B cell infection with hepatitis C 
(50), Epstein-Barr virus (51, 52), or Moloney murine leukemia 
virus (53) leads to AID up-regulation, suggesting that AID 
induction is part of a general innate antiviral host response. 
It will be important to determine whether non–B cells upon 
viral infection can also trigger AID expression.
In conclusion, our AID indicator strains effi   ciently track 
B cells expressing AID and their progeny in the context of 
the humoral immune response. These animals along with 
similar B cell activation reporter mice, such as Blimp-EGFP 
(54) and Cγ1-Cre (55) transgenics, will further our knowl-
edge of the late stages of B cell diff  erentiation both in the 
normal immune response as well as during autoimmunity and 
B cell tumorigenesis.
MATERIALS AND METHODS
Phylogenetic footprinting and histone H3 acetylation. Resting splenic 
B lymphocytes were isolated by negative selection using CD43 MACS beads 
and processed directly for chromatin immunoprecipitation or cultured at 
7 × 105 cells ml−1 in the presence of 25 μg ml−1 LPS (Escherichia coli 0111:B4; 
Sigma-Aldrich) for 3 d.
To immunoprecipitate acetylated histone H3–DNA complexes from 
resting and activated B cells, we used anti–acetyl-histone H3 antibodies 
(06-599; Upstate Biotechnology) according to the manufacturer’s instruc-
tions. On average, 85 ng of acetylated DNA was recovered per 106 cells. 
To calculate the absolute percentage of acetylated histone H3 for a given 
genomic target, we amplifi  ed 4 ng anti–acetyl-histone H3 immunoprecipi-
tated (IM) and input (IN) DNA (normalized using PicoGreen, P7589; 
Invitrogen) in the presence of SYBR Green (4309155; Applied Biosystems) 
using an iCycler (Bio-Rad Laboratories). Primers were designed to scan 
the mouse AID locus at  500-bp intervals. PCR products were between 
100 and 150 bp in length. The fold diff  erence between the two sets of 
  samples for any given target sequence was calculated using the following 
PCR equation:
   =  (1 + E)
n
0 XX  (1)
where X0 and X represent the DNA concentration before and after 
PCR amplifi  cation, respectively, E denotes the PCR effi   ciency and n repre-
sents the number of cycles necessary to achieve a specifi  ed threshold, which 
we set to cross a point at which amplifi  cation was linear (110 RFU using 
software from Bio-Rad Laboratories). Under these conditions, X becomes a 
constant and the ratio of the initial DNA abundance between the IM and the 
IN fractions can be calculated as follows:
  (IM) (IN) (IM)/ (IN) = 2
nn
00 XX
-  (2)
Thus, the fold diff  erence between the immunoprecipitated and input 
samples is determined as the diff  erence in number of cycles each fraction 
takes to reach the specifi  ed threshold and taking the resulting power of 2. 
The fold diff  erence X0(IM)/X0(IN) is also proportional to the percentage of 
acetylated histone H3 in the immunoprecipitated sample (%AcIM) over that 
of the input (%AcIN):
  (IM) (IN)
IM IN (IM)/ (IN) = 2  = %Ac /%Ac
nn
00 XX
-  (3)
Thus, the absolute percentage of histone H3 at any given genomic site 
can be assessed if %AcIN is known. To empirically determined %AcIN, we 
measured the total fraction (f) of the genome that can be pulled down by 
immunoprecipitation in the presence of an excess of anti-acetylated H3 anti-
body as follows:
  IM IN DNA  = f DNA    B +  (4)
where DNAIN and DNAIM are the amount of DNA measured before 
and after immunoprecipitation, respectively, and B represents nonspecifi  c 
DNA pulled down by the antibody, which is constant when the immuno-
precipitating antibody is in excess. To determine f, we performed several 1154  AID REPORTER MICE | Crouch et al.
  dilutions of cross-linked DNA obtained from B lymphocytes and measured, 
using PicoGreen, the absolute concentration of DNA before and after 
  immunoprecipitation (performed in the presence of 100 μl anti-acetylated 
H3 antibody). By plotting DNAIM versus DNAIN and using linear regression 
analysis, we determined the slope f (0.08, Fig. 2 B) and concluded that 8% of 
all histone H3 is acetylated at any one point in time in the mammalian ge-
nome. This measurement is comparable to what has been previously deter-
mined for chicken cells (7%) (22). Therefore, by using the fold diff  erence 
calculated by real-time PCR analysis, we can now assess the percentage of 
histone H3 acetylated at any given target in mammalian cells:
  *
(IM) (IN)
IM %Ac  = 0.08   2
nn -  (5)
DNaseI hypersensitivity. B lymphocytes were isolated using CD43 
MACS beads and cultured in the presence of 25 μg ml−1 LPS or 1 μg/ml 
anti-CD40 (HM40-3; BD Biosciences) and 25 ng ml−1 IL-4 (404-ML; 
R&D Systems) for 36 h. Resting and activated B cells were then washed, 
and the nuclei were isolated followed by exposure for 20 min at 37°C to in-
creasing amounts of 10 U μl−1 DnaseI (diluted 1/160, 1/320, 1/640, 
1/1280, 1/2560, 1/5120 and 1/10240, respectively; 92877720; Roche). 
The reaction was terminated with EDTA. Next, the nuclei were treated for 
30 min at 37°C with RNase A (0.5 mg ml−1 DNase-free RNase A in TE) 
followed by incubation overnight with proteinase K at 55°C. The DNA was 
precipitated, resuspended in 20 μl TE, digested overnight with EcoRV or 
XbaI, and fractionated on Southern blots probed with 32P-labeled DNA 
fragments designated PI and PII. These probes were generated by PCR am-
plifi  cation using primer pairs 2B-5′ (T  G  T  G  T  T  G  A  G  G  T  T  T  C  A  T  A  T  C  G  C  C  ) 
and 2B-3′ (C C  A  G  C  A  C  T  T  G  G  G  A  G  G  C  A  A  A  G  ), and 7B-5′ (T C  T  C  C  A  G  C-
C  C  T  G  G  A  A  A  C  T  T  A  T  G  ) and 7B-3′ (C  T  T  G  G  T  C  A  C  C  T  A  C  A  A  G  G  A  A  C-
T  C  ), respectively.
Generation of AID-GFP, AID-GFP𝖫X, and AID-Cre transgenic 
mice. BAC transgenes were constructed by modifi  cation of a 200-kb mouse 
BAC containing mouse Aicda (RPCI24-68I7). Deletions and insertions 
were generated using homologous recombination in bacteria as described 
previously (25). In brief, 1–2-kb constructs carrying two arms of homology 
( 500 each) were ligated into the PsVI shuttle vector that was transformed 
into DH10B-competent cells expressing the RPCI24-68I7 BAC. The 
proper insertion of the respective modifi  cations and fi  nal bacterial selec-
tion in chloramphenicol/fusaric acid plates were monitored by PCR using 
primers internal and external to the homologous constructs. By this method, 
two deletions were performed fl  anking the Aicda gene within the RPCI24-
68I7 BAC. The 3′ deletion consisted of a 110.7-kb DNA fragment starting 
13,717 bp 3′ of AID exon 5 and ending at the T7 promoter of the pTAR-
BAC backbone vector of RPCI24-68I7. The 5′ deletion consisted of  37 kb 
DNA starting 25,202 bp 5′ of AID exon 1 and ending at the SP6 pro-
moter of pTARBAC. Finally, the GFP gene was introduced in such a way 
as to create a fusion to AID exon 5. To generate the AID-GFP∆X trans-
genic construct, a 6-kb XbaI fragment containing CNS-X (3,905–9,917 bp 
downstream of mouse AID exon 5) was deleted from the trimmed BAC. 
Alternatively, the bacterial Cre recombinase gene was inserted in lieu of 
AID exon 1 so that only the recombinase (and not AID) would be ex-
pressed from the transgene. As an example of the strategy used to clone and 
select the aforementioned constructs, primers used to amplify the 5′ arm 
of AID-Cre were: 5′(1) aagtcgacC  C  A  A  T  G  T  G  A  G  A  A  G  T  G  T  C  C  A  G  T  G   
and 5′(2) G  T  G  T  A  C  G  G  T  C  A  G  T  A  A  A  T  T  G  G  A  C  A  T  atcggtctccagcgtgactttc; 
to amplify the 3′ arm: 3′(1) C  T  G  C  T  G  G  A  A  G  A  T  G  G  C  G  A  T  T  A  G  G  G  A  C-
A  G  gtaacaagacagtc and 3′(2) gtcgacagtaA  G  G  A  G  T  T  G  C  T  A  C  G  A  C  C  T  C  ; 
and the Cre gene was amplifi  ed with Cre1 gaaagtcacgctggagaccgatA  T  G-
T  C  C  A  A  T  T  T  A  C  T  G  A  C  C  G  T  A  C  A  C   and Cre2 gactgtcttgttacC  T  G  T  C  C-
C  T  A  A  T  C  G  C  C  A  T  C  T  T  C  C  A  G  C  A  G  . To create the fi  nal  homologous 
recombination construct, 10 ng of each of the DNA fragments was fused 
in a PCR reaction using primers 5′(1) and 3′(2). The DNA piece was 
then extracted, sequenced, digested with SalI, and ligated to PsVI. To as-
sess recombination of the construct’s right arm we used primers Cre5′(1) 
C  A  C  A  C  T  C  A  C  A  G  A  G  C  T  C  A  T  T  A  T  C  A  T  G   and Cre5′(2) G T  T  G  C  A  T  C  G-
A  C  C  G  G  T  A  A  T  G  C  A  G  , whereas left arm recombinations were determined 
with Cre3′(1) A  T  C  C  G  T  A  A  C  C  T  G  G  A  T  A  G  T  G  A  A  A  C  A  G   and Cre3′(2) 
C  C  A  T  G  C  G  A  G  T  C  T  T  A  A  G  A  T  G  T  T  G  G  .
All animal experiments were performed according to the NIH guide-
lines for laboratory animals and were approved by the Scientifi  c Committee 
of the NIAMS Animal Facility.
RT-PCR and SC-RT-PCR. To discriminate and compare endogenous 
AID and transgenic AID-GFP transcripts, splenic B cells from AID-GFP 
(and AID-GFP-∆X) mice were isolated with CD43 microbeads and cul-
tured in the presence of LPS or LPS plus IL-4 for 48 h. RNA was extracted 
with RNAqueous-Micro (Ambion) and treated twice with DNaseI. cDNA 
was generated, and the level of endogenous AID transcripts were monitored 
by real-time PCR with primers: AIDWT-RT5′: C  C  C  T  T  G  T  A  C  G  A  A  G-
T  C  G  A  T  G  A  C  , AIDWT-RT3′: A  T  C  A  C  G  T  G  T  G  A  C  A  T  T  C  C  A  G  G  A  G  . 
AID-GFP transcripts were amplifi  ed with: AID-GFP-RT5′: G  A  C  T  T  G  C  G-
A  G  A  T  G  C  A  T  T  T  C  G  T  A  T  G   and AID-GFP-RT3′: G  C  T  G  A  A  C  T  T  G  T  G  G-
C  C  G  T  T  T  A  C  . To determine the fold diff  erence between diff  erent samples, 
cDNA obtained from AID-GFP–activated B cells was diluted twofold, fi  ve-
fold, 10-fold, 50-fold, and 100-fold, and both endogenous AID and AID-
GFP were amplifi  ed by real-time PCR. We normalized cDNA between 
samples by amplifying from each cDNA reaction the DNA-PK subunit 
Ku70 mRNA with the following primers: Ku70-5′: T  G  C  C  C  T  T  T  A  C  T  G  A-
G  A  A  G  G  T  G  A  C   and Ku70-3′: T  G  C  T  G  C  A  G  G  A  C  T  G  G  A  T  T  C  T  C  .
To quantify AID transcription in diff   erent B cell compartments 
(Fig. 4), mouse AID primer sequences were obtained from PrimerBank 
(http://pga.mgh.harvard.edu/primerbank/index.html): PrimerBank-mAID5′: 
G  C  C  A  C  C  T  T  C  G  C  A  A  C  A  A  G  T  C  T   and PrimerBank-mAID3′: C  C  G  G  G  C-
A  C  A  G  T  C  A  T  A  G  C  A  C  .
To analyze AID expression at the single cell level, B lymphocytes were 
stained as indicated and individual cells were sorted using a MoFlo (Dako-
Cytomation) instrument into iCycler 96-well plates (Bio-Rad Laborato-
ries) containing 10 μl of 10 mM RNAase-Free Tris buff  er and 1 U/μl of 
RNase inhibitor (Promega). RT-PCR was set up by adding to each well 
15 μl of QIAGEN’s OneStep RT-PCR master mix plus 0.6 μM of 
  PrimerBank primers (described above). The plates were incubated (iCycler; 
Bio-Rad Laboratories) at 50°C for 30 min, followed by a 15-min cycle at 
95°C and 40 cycles of 10 s at 95°C and 30 s at 55°C. Samples were run in a 
2% agarose gel.
Hypermutation analysis. GC or activated B cells were sorted using a 
  MoFlo high-speed cell sorter (DakoCytomation). Genomic DNA was isolated, 
and the JH4 intron was amplifi  ed by nested PCR using KOD DNA poly-
merase (Novagen) and primers V1: A  G  C  C  T  G  A  C  A  T  C  T  G  A  G  G  A  C   and V2: 
T  A  G  T  G  T  G  G  A  A  C  A  T  T  C  C  T  C  A  C   for 30 cycles at 55°C. The second am-
plifi  cation step was performed with primers V3: C  T  G  A  C  A  T  C  T  G  A  G  G  A  C-
T  C  T  G  C   and V4: G  C  T  G  T  C  A  C  A  G  A  G  G  T  G  G  T  C  C  T  G   for 30 cycles at 
60°C. PCR products were cloned using ZERO-blunt PCR cloning kit (In-
vitrogen) and sequenced using M13 universal primers. Sequence analysis was 
performed using SeqMan software (DNASTAR).
FACS analysis. Unless otherwise stated, all other antibodies were from BD 
Biosciences: B220-PercP-Cy5.5, B220-APC-Cy7, B220-FITC, IgM-APC 
(Jackson ImmunoResearch Laboratories), CD95-PE, CD95-PE-Cy7, GL7-
FITC, GL7-APC (APC conjugation was performed using Phycolink from 
Prozyme), CD43-PE, CD93-biotin, CD138-PE, CD4-PE-Cy5, CD8-PE-
Cy5, IgA-Biotin, IgG1-biotin, GR1-Alexa 647 and F4/80-Alexa 647 
(eBiosciences), IgD-Biotin, IgD-Alexa 647, Streptavidin-APC,  Streptavidin-
PE-Cy5, Streptavidin-PercP-Cy5.5, Streptavidin-PE, NP-APC (provided 
by McHeyzer-Williams), and NP-PE (Biosearch Technologies). Apoptotic 
cells were gated out using To-Pro-3 (Invitrogen) or DAPI (Sigma-Aldrich). 
Flow cytometers used were FACSCalibur (Becton Dickinson) and Cyan 
(DakoCytomation) for acquisition and MoFlo (DakoCytomation) for sort-
ing. FACS data was analyzed with FlowJo software.JEM VOL. 204, May 14, 2007  1155
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Online supplemental material. Fig. S1 shows expression of AID mRNA 
by RT-PCR analysis in diff  erent tissues of wild-type, AID-GFP, and AID-
Cre-YFP transgenic mice. It is available at http://www.jem.org/cgi/content/
full/jem.20061952/DC1.
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